OOIR: Observatory of International Research

Papers

(The median citation count of Biosocieties is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Publisher Correction: Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria	14
Sexual health as surplus: the marketization of PrEP in Taiwan	12
Deploying nationalist discourses to reduce sex-, gender- and HIV-related stigma in Thailand	12
Discipline for pleasure: a new governmentality of HIV prevention	12
Conceptualization of genotype–phenotype relationships and the assessment of risk in advertising of direct-to-consumer and preimplantation polygenic tests	11
Cell freezing and the biology of inexorability: on cryoprotectants and chemical time	10
“Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation	10
“An entire career in 10 seconds”: on protein chemistry, AI, and the threat of obsolescence	10
Mapping ‘bio geo-body’ of Southeast Asia: strategic differentiation and identification of ethnic identity in Vietnam and Singapore	9
Hormonal stories: a new materialist exploration of hormonal emplotment in four case studies	9
Genome editing: From bioethics to biopolitics	8
Molecular sovereignties: patients, genomes, and the enduring biocoloniality of intellectual property	7
Adjusting the analytical aperture: propositions for an integrated approach to the social study of reproductive technologies	7
Bleak Biopolitics and Abolitionist Aspirations: Recent Books on Race	7
Agri-food tech’s building block: narrating protein, agnostic of source, in the face of crisis	7
Beyond secrecy and openness: telling a relational story about children’s best interests in donor-conceived families	6
“The elephant in the room”: social responsibility in the production of sociogenomics research	6
What to do with the new molecular publics: the vernacularization of pathogen genomics and the future of infectious disease biosocialities	6
The evolution, devolution and distribution of UK Biometric Imaginaries	6
Challenges in public policy for the implementation of pharmacogenetic tests in Europe	6
Accept no limits: biocontainment and the construction of a safer space for experimentation in xenobiology as a legacy of Asilomar	5
Epistemology of the side effect: anecdote and evidence in the digital age	5
Openness in donor conception families	5
Post-identifiability in changing sociotechnological genomic data environments	5
Pharmaceutical innovation and its crisis: drug markets, screening, and the dialectics of value	4

Introduction to the special issue: Politics of suspension? Time, space, and control in cryopreservation practices	4
Beyond controversies in child mental health: negotiating autism and ADHD diagnosis in France and Brazil	4
Making death through producing life: Necrovalue and the political economy of death	4
Ectogenesis, inequality, and coercion: a reproductive justice-informed analysis of the impact of artificial wombs	4
Psychedelic innovations and the crisis of psychopharmacology	4
It’s all about kids, kids, kids! Negotiating reproductive citizenship and patient-centred care in ‘factory IVF’	4
Correction: An imagined future community: Taiwan Biobank, Taiwanese genome, and nation-building	3
Correction to: The other face of medical globalization? Pharmaceutical data, prescribing trends, and the social localization of psychostimulants	3
Negotiating the necessity of biomedical animal use through relations with vulnerability	3
Value-creation in the health data domain: a typology of what health data help us do	3
Allostatic load: historical origins, promises and costs of a recent biosocial approach	3
Donors we choose: race, nation and the biopolitics of (queer) assisted reproduction in Scandinavia	2
Good donors, bad donors and oddities in the family tree: genomics, donation and reproductive citizenship in Finnish egg donor accounts	2
Formatting patient knowledge and channelling participation: how patient organisations work under authoritarianism	2
Anticipating and suspending: the chronopolitics of cryopreservation	2
“Is your brain in danger of overheating?”: neurobiologizing the labouring subject in cognitive capitalism	2
Navigating biosafety concerns within COVID-19 do-it-yourself (DIY) science: an ethnographic and interview study	2
Making valuable health: pharmaceuticals, global capital and alternative political economies	2
Afterword: the politics of suspension as an analytical gestalt switch	2
Diversity via datafication? Digital patient records and citizenship for sexuality and gender diverse people	2
Styles of thought in healthcare governance: A situational analysis of English PrEP discourse 2016–2020	2
The normal is pathological: semi-conscious brains, mindless habits, and the paradoxical science of mindfulness	2
Foetal programming meets human capital: biological plasticity, development, and the limits to the economization of life	2
Correction: Reproducing the normal and the pathological in personalized cancer medicine clinical trials	2
‘Nonetheless biosocial’: experiences and embodied knowledge of birth cohort participants in the UK and Brazil	2
Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria	2
Antibiotics in the environment: molecularisation, drug resistance and pharmaceutical pollution in India	2
Correction to: Epidemiologists’ ambivalence towards the epigenetics of social adversity	2
Population anxieties in constituting Nordic welfare state futures: affective biopolitics in the age of environmental crises	2
Making epistemic goods compatible: knowledge-making practices in a lifestyle intervention RCT on mindfulness and compassion meditation	1
Correction: Core values of genomic citizen science: results from a qualitative interview study	1
Reproducing the normal and the pathological in personalized cancer medicine clinical trials	1
Reprowebs: a conceptual approach to elasticity and change in the global assisted reproduction industry	1
Living in the era of codes: a reflection on China’s health code system	1
The other face of medical globalization? Pharmaceutical data, prescribing trends, and the social localization of psychostimulants	1
‘Healthy’ for whom? ‘Healthy’ food’s effectivities, avocados, and the production of differentiated bodies	1
Inscrutable futures: biotechnology, architecture, and planetary ecology in late industrial China	1
In whose pockets? How small Danish patient organisations balance legitimacy, representation and dependency in collaboration with public sector medical researchers and the life science industry	1
Guardians of ableist family formation: the legitimation work of Danish abortion committees in cases of termination for fetal anomaly	1
Paradoxical bodies: negotiating biomedical fix, responsibility, and care in a weight-loss surgery clinic	1
More than sample providers: how genetic researchers in Pakistan mobilized a prenatal diagnostic service for thalassemia	1
The effects of COVID-19 on imagined reproductive futures	1
To wish you well: the biopolitical subjectivities of medical crowdfunders during and after Aotearoa New Zealand’s COVID-19 lockdown	1
‘Our biology is listening’: biomarkers as molecular vestiges of early life and the production of positive childhood experiences in behavioral epigenetics	1
‘Braining’ psychiatry: an investigation into how complexity is managed in the practice of neuropsychiatric research	1
“Being useful, I think it's the result of a sick society”: Critical reflections on reproductive politics and markets by women freezing their eggs in Spain	1